Relevance of Animal Models to Human Tardive Dyskinesia
Overview
Psychology
Social Sciences
Affiliations
Tardive dyskinesia remains an elusive and significant clinical entity that can possibly be understood via experimentation with animal models. We conducted a literature review on tardive dyskinesia modeling. Subchronic antipsychotic drug exposure is a standard approach to model tardive dyskinesia in rodents. Vacuous chewing movements constitute the most common pattern of expression of purposeless oral movements and represent an impermanent response, with individual and strain susceptibility differences. Transgenic mice are also used to address the contribution of adaptive and maladaptive signals induced during antipsychotic drug exposure. An emphasis on non-human primate modeling is proposed, and past experimental observations reviewed in various monkey species. Rodent and primate models are complementary, but the non-human primate model appears more convincingly similar to the human condition and better suited to address therapeutic issues against tardive dyskinesia.
Cannabigerol Mitigates Haloperidol-Induced Vacuous Chewing Movements in Mice.
Ponciano R, Hallak J, Crippa J, Guimaraes F, Bel E Neurotox Res. 2024; 43(1):2.
PMID: 39699828 DOI: 10.1007/s12640-024-00724-0.
Shoae-Hagh P, Razavi B, Sadeghnia H, Mehri S, Karimi G, Hosseinzadeh H Mol Neurobiol. 2024; 62(4):5156-5182.
PMID: 39520654 DOI: 10.1007/s12035-024-04566-x.
Dovonou A, Bolduc C, Soto Linan V, Gora C, Peralta Iii M, Levesque M Transl Neurodegener. 2023; 12(1):36.
PMID: 37468944 PMC: 10354932. DOI: 10.1186/s40035-023-00368-8.
Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies.
Tsermpini E, Redensek S, Dolzan V Front Pharmacol. 2022; 12:834129.
PMID: 35140610 PMC: 8819690. DOI: 10.3389/fphar.2021.834129.
Management of Tardive Syndrome: Medications and Surgical Treatments.
Factor S Neurotherapeutics. 2020; 17(4):1694-1712.
PMID: 32720245 PMC: 7851276. DOI: 10.1007/s13311-020-00898-3.